X. Deng, PhD, J.-J. Wei, MD, and S. Zhang, MD, “Screening Genetic Alterations of Biomarkers BRAF, ROS-1, and HER2 by Immunohistochemistry in Ovarian Carcinomas for Targeted Therapy”, N A J Med Sci, vol. 10, no. 2, Apr. 2017.